Literature DB >> 9298338

Does EMG (dry needling) reduce myofascial pain symptoms due to cervical nerve root irritation?

J Chu1.   

Abstract

OBJECTIVE: EMG examination at tender points affects myofascial pain symptoms related to cervical nerve root irritation.
METHODS: Consecutive patients with neck and arm pain had physical examinations immediately before and after having EMGs of bilateral C3-C8 myotomes. Patients were randomly chosen for EMG either at the most tender point along the palpated myofascial band or at a nonselected site. The myotomal presence of > or = 30% incidence of normal duration and amplitude, and polyphasic motor unit potentials confirm the diagnosis of cervical nerve root irritation.
RESULTS: 52% returned patient questionnaires 2 weeks post EMG examination. Group I (82/122 patients [67.2%]), averaged pain relief of 51.8 +/- 21.9%, a mean of 10.2 +/- 8 days; 14% had > or = 75% relief. The number of days of pain relief correlated positively with the percentage of pain relief (p < 0.005), but negatively with the number of nerve roots involved on EMG (p < 0.05). Group 2 (23/42 patients [54.8%]), averaged relief of 39.0 +/- 18.7%, lasting 8.8 +/- 11.2 days. None had > or = 75% pain relief. Both groups' duration of pain symptoms affected onset of relief. Evidence of bilateral multiple-level cervical nerve root irritation, especially noted at bilateral C6 and C7 levels.
CONCLUSION: EMG at tender points on myofascial bands tends to improve symptoms. Needling these points elicits motor endplate activity and twitches, and induces more relief than when needling random points.

Entities:  

Mesh:

Year:  1997        PMID: 9298338

Source DB:  PubMed          Journal:  Electromyogr Clin Neurophysiol        ISSN: 0301-150X


  15 in total

Review 1.  The neurophysiology of myofascial pain syndrome.

Authors:  M H Rivner
Journal:  Curr Pain Headache Rep       Date:  2001-10

2.  STRENGTH EXERCISES COMBINED WITH DRY NEEDLING WITH ELECTRICAL STIMULATION IMPROVE PAIN AND FUNCTION IN PATIENTS WITH CHRONIC ROTATOR CUFF TENDINOPATHY: A RETROSPECTIVE CASE SERIES.

Authors:  Estee Saylor-Pavkovich
Journal:  Int J Sports Phys Ther       Date:  2016-06

3.  DRY NEEDLING FOR MYOFASCIAL TRIGGER POINT PAIN: A CLINICAL COMMENTARY.

Authors:  Casey Unverzagt; Kathy Berglund; J J Thomas
Journal:  Int J Sports Phys Ther       Date:  2015-06

4.  Dry needling of the trapezius muscle in office workers with neck pain: a randomized clinical trial.

Authors:  Ester Cerezo-Téllez; María Torres Lacomba; Isabel Fuentes-Gallardo; Orlando Mayoral Del Moral; Beatriz Rodrigo-Medina; Carlos Gutiérrez Ortega
Journal:  J Man Manip Ther       Date:  2016-09

Review 5.  WITHDRAWN: Acupuncture for neck disorders.

Authors:  Kien Trinh; Nadine Graham; Dominik Irnich; Ian D Cameron; Mario Forget
Journal:  Cochrane Database Syst Rev       Date:  2016-11-17

6.  The use of dry needling for a subject with acute onset of neck pain: a case report.

Authors:  Ron Pavkovich
Journal:  Int J Sports Phys Ther       Date:  2015-02

Review 7.  Dry needling for management of pain in the upper quarter and craniofacial region.

Authors:  David M Kietrys; Kerstin M Palombaro; Jeffrey S Mannheimer
Journal:  Curr Pain Headache Rep       Date:  2014

8.  The effect of dry needling in the treatment of myofascial pain syndrome: a randomized double-blinded placebo-controlled trial.

Authors:  Levent Tekin; Selim Akarsu; Oğuz Durmuş; Engin Cakar; Umit Dinçer; Mehmet Zeki Kıralp
Journal:  Clin Rheumatol       Date:  2012-11-09       Impact factor: 2.980

9.  Probable mechanisms of needling therapies for myofascial pain control.

Authors:  Li-Wei Chou; Mu-Jung Kao; Jaung-Geng Lin
Journal:  Evid Based Complement Alternat Med       Date:  2012-12-31       Impact factor: 2.629

10.  Remote subcutaneous needling to suppress the irritability of myofascial trigger spots: an experimental study in rabbits.

Authors:  Zhonghua Fu; Yueh-Ling Hsieh; Chang-Zern Hong; Mu-Jung Kao; Jaung-Geng Lin; Li-Wei Chou
Journal:  Evid Based Complement Alternat Med       Date:  2012-12-25       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.